🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This trial is a multi-center, open label, randomized controlled, non-inferi...
Status
Completed
Location
Jefferson County Department of Health
Start Date
2019-11-06
Trial ID
NCT03959527
Treatments Being Tested
The Phase I Thorough QT/QTc (TQT) study will be performed in a single cente...
Status
Completed
Location
Vince and Associates Clinical Research
Start Date
2018-09-25
Trial ID
NCT03613649
Treatments Being Tested
This is a multi-center Phase 2 randomized, open-label study in approximatel...
Status
Completed
Location
Jefferson County Department of Health - STD Clinic
Start Date
2014-11-25
Trial ID
NCT02257918
Treatments Being Tested
This study will investigate the metabolic fate and routes of excretion of 1...
Status
Completed
Location
Covance Clinical Research Unit
Start Date
2015-01
Trial ID
NCT02298920
Treatments Being Tested
The purpose of this study is to assess the safety and tolerability of orall...
Status
Completed
Location
Research Site
Start Date
2013-09
Trial ID
NCT01929629
This study is a randomized, double-blind, placebo-controlled clinical trial...
Status
Not Yet Recruiting
Location
Parexel EPCU
Start Date
2026-10
Trial ID
NCT07640477
Treatments Being Tested
This is a phase I, parallel, open-label, randomized, cross-over, single-cen...
Status
Completed
Location
Quotient Sciences
Start Date
2018-10-03
Trial ID
NCT03718806
Treatments Being Tested
this study will be a Phase 1, single-dose, two parallel cohorts, open-label...
Status
Completed
Location
Parexel Early Phase Clinical Unit
Start Date
2022-11-09
Trial ID
NCT05635305
Treatments Being Tested
The trial is to evaluate the pharmacokinetics and safety profiles of the si...
Status
Completed
Location
Quintiles Phase I Services - Overland Park
Start Date
2018-02-02
Trial ID
NCT03404167
Treatments Being Tested